Banys-Paluchowski M, Hartmann S, Basali T, Gasparri ML, de Boniface J, Gentilini OD, Cakmak GK, Ditsch N, Stickeler E, Schlichting E, Rubio I, Peintinger F, Untch M, Mau C, Federspiel FK, Bucher S, Ramaker K, Paluchowski P, Bauer L, Riemer S, Langanke D, Leuf TD, Schnabel J, von Abel E, Solbach Cet al.(2025) Radar reflectors for marking of target lymph nodes in initially node-positive patients receiving neoadjuvant chemotherapy for breast cancer-a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial Breast Cancer Res Treat(in press) DOI 10.1007/s10549-025-07635-4, PubMed 39976867
Hyldebrandt HK, Stormorken AT, Vitelli V, Mæhle L, Schlichting E, Grindedal EM(2024) Risk reducing mastectomy in Norwegian BRCA1/2 carriers Eur J Surg Oncol, 51(3), 109571(in press) DOI 10.1016/j.ejso.2024.109571, PubMed 39765192
Vandraas K, Reinertsen KV, Gudim HB, Bowen CA, Gjerdalen G, Schlichting E, Naume B, Sætersdal A(2024) [Not Available] Tidsskr Nor Laegeforen, 144(12) DOI 10.4045/tidsskr.24.0182, PubMed 39404245